Patient education is primarily focused on treatment; however, patients should also be advised about their increased risk of cancer, particularly gastric, and pernicious anemia’s association with other autoimmune disorders. Clinicians must recognize proper adherence to lifelong treatment and monitoring requires consideration of the patient’s preferred route of vitamin B12 supplementation. Patients choosing oral therapy may confuse it with optional self-supplementation, and those who choose IM injections may require education regarding self-administration. Furthermore, patients may inadvertently discontinue treatment when their symptoms improve or resolve. Ongoing patient education improves the chances of patients adhering to the necessary lifelong treatment and monitoring. They must also be educated on the signs and symptoms of other autoimmune disorders and gastric malignancies to improve their chances of earlier diagnosis and treatment.